文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

全身计算机断层扫描与多发性骨髓瘤患者常规骨骼扫描的比较:国际骨髓瘤工作组的一项研究。

Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group.

机构信息

Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.

Department of Radiology, German Cancer Research Center, Heidelberg, Germany.

出版信息

Blood Cancer J. 2017 Aug 25;7(8):e599. doi: 10.1038/bcj.2017.78.


DOI:10.1038/bcj.2017.78
PMID:28841211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5596388/
Abstract

For decades, conventional skeletal survey (CSS) has been the standard imaging technique for multiple myeloma (MM). However, recently whole-body computed tomography (WBCT) has been implemented into the diagnostic criteria of MM. This analysis compares sensitivity and prognostic significance of WBCT and CSS in patients with smoldering MM (SMM) and MM. Fifty-four of 212 patients (25.5%) had a negative CSS and a positive WBCT for osteolytic lesions (P<0.0001). Of 66 patients with SMM based on CSS, 12 (22.2%) had osteolytic lesions on WBCT. In comparison, WBCT failed to detect some bone destructions in the appendicular skeleton possibly due to limitations of the field of view. Presence of lytic bone lesions in WBCT was of borderline prognostic significance (P=0.051) for SMM patients, with a median time to progression of 38 versus 82 months for those without bone destructions. In conclusion, WBCT identifies significantly more sites of bone destruction than CSS. More than 20% of patients with SMM according to CSS have in fact active MM detectable with WBCT. On the basis of this and other studies, WBCT (either computed tomography (CT) alone or as part of a positron emission tomography-CT protocol) should be considered the current standard for the detection of osteolytic lesions in MM.

摘要

几十年来,传统的全身骨骼检查(CSS)一直是多发性骨髓瘤(MM)的标准影像学检查技术。然而,最近全身计算机断层扫描(WBCT)已被纳入 MM 的诊断标准。本分析比较了冒烟型多发性骨髓瘤(SMM)和 MM 患者中 WBCT 和 CSS 的敏感性和预后意义。在 212 例患者中,54 例(25.5%)CSS 阴性而 WBCT 阳性存在溶骨性病变(P<0.0001)。在基于 CSS 的 66 例 SMM 患者中,12 例(22.2%)在 WBCT 上存在溶骨性病变。相比之下,WBCT 可能由于视野限制而未能检测到四肢骨骼的一些骨质破坏。WBCT 存在溶骨性骨病变对 SMM 患者具有边界预后意义(P=0.051),无骨质破坏的患者中位进展时间为 38 个月,而有骨质破坏的患者为 82 个月。总之,WBCT 比 CSS 识别出更多的骨破坏部位。根据 CSS,超过 20%的 SMM 患者实际上存在可通过 WBCT 检测到的活动性 MM。基于这一研究和其他研究,WBCT(单独 CT 或作为正电子发射断层扫描-CT 方案的一部分)应被视为 MM 溶骨性病变检测的当前标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb7/5596388/6ca352ecbbdd/bcj201778f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb7/5596388/8fe72a594425/bcj201778f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb7/5596388/5d3fe4f5b182/bcj201778f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb7/5596388/abf2c2ecee52/bcj201778f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb7/5596388/6ca352ecbbdd/bcj201778f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb7/5596388/8fe72a594425/bcj201778f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb7/5596388/5d3fe4f5b182/bcj201778f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb7/5596388/abf2c2ecee52/bcj201778f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb7/5596388/6ca352ecbbdd/bcj201778f4.jpg

相似文献

[1]
Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group.

Blood Cancer J. 2017-8-25

[2]
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease.

Leukemia. 2015-10-22

[3]
Detection of Skeletal Lesions by Whole Body Multidetector Computed Tomography in Multiple Myeloma has no Impact on Long-Term Outcomes Post Autologous Hematopoietic Cell Transplantation.

World J Oncol. 2012-8

[4]
A prospective study of Skeletal survey versus Low-dose whole-body CT for Osteolytic lesions in Multiple Myeloma.

Eur J Haematol. 2022-5

[5]
Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma.

Cancers (Basel). 2020-2-19

[6]
[Radiological diagnostics of multiple myeloma].

Radiologe. 2014-6

[7]
Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography.

Eur J Radiol. 2016-12

[8]
Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states.

Skeletal Radiol. 2019-5

[9]
Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy.

Blood Cancer J. 2015-10-23

[10]
Rapid study assessment in follow-up whole-body computed tomography in patients with multiple myeloma using a dedicated bone subtraction software.

Eur Radiol. 2020-2-11

引用本文的文献

[1]
Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease.

Cancer Pathog Ther. 2024-12-18

[2]
Imaging in plasma cell disorders-consensus recommendations of the Asian myeloma network bone imaging workgroup.

Lancet Reg Health West Pac. 2025-6-7

[3]
Observation or treatment for smoldering multiple myeloma? A systematic review and meta-analysis of randomized controlled studies.

Blood Cancer J. 2025-5-26

[4]
[Expert consensus on the comprehensive management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma in China (2025)].

Zhonghua Xue Ye Xue Za Zhi. 2025-3-14

[5]
Treatment of myeloma bone disease: When, how often, and for how long?

J Bone Oncol. 2025-4-1

[6]
Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice.

J Clin Med. 2025-3-25

[7]
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma.

J Bone Oncol. 2025-2-28

[8]
Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions.

Diagnostics (Basel). 2025-1-18

[9]
Role of Imaging in Multiple Myeloma: A Potential Opportunity for Quantitative Imaging and Radiomics?

Cancers (Basel). 2024-12-7

[10]
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma.

Blood Adv. 2025-2-11

本文引用的文献

[1]
Role of F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.

Lancet Oncol. 2017-4

[2]
Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients.

Haematologica. 2016-10

[3]
The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.

Am Soc Clin Oncol Educ Book. 2016

[4]
Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy.

Blood Cancer J. 2015-10-23

[5]
European Myeloma Network guidelines for the management of multiple myeloma-related complications.

Haematologica. 2015-10

[6]
Clinical and prognostic significance of bone marrow abnormalities in the appendicular skeleton detected by low-dose whole-body multidetector computed tomography in patients with multiple myeloma.

Blood Cancer J. 2015-7-31

[7]
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.

J Clin Oncol. 2015-1-20

[8]
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Lancet Oncol. 2014-10-26

[9]
Non-osseous incidental findings in low-dose whole-body CT in patients with multiple myeloma.

Br J Radiol. 2014-9

[10]
Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease.

Eur J Radiol. 2014-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索